(Q35314724)

English

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 August 2017

A comparison of latanoprost and dorzolamide in patients with glaucoma and ocular hypertension: a 3 month, randomised study. Ireland Latanoprost Study Group (English)

1 reference

Europe PubMed Central

7 August 2017

ocular hypertension

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

O'Donoghue EP

1

1 reference

Europe PubMed Central

7 August 2017

language of work or name

0 references

publication date

1 June 2000

1 reference

Europe PubMed Central

7 August 2017

British Journal of Ophthalmology

1 reference

Europe PubMed Central

7 August 2017

84

1 reference

Europe PubMed Central

7 August 2017

6

1 reference

Europe PubMed Central

7 August 2017

579-582

1 reference

Europe PubMed Central

7 August 2017

Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2 alpha analogue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

27 July 2018

Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

26 September 2018

Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

26 September 2018

A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

26 September 2018

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1723499

26 September 2018

Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/10837379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

https://pubmed.ncbi.nlm.nih.gov/10837379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10837379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/10837379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BJO.84.6.579

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

1 reference

Europe PubMed Central

7 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35314724&oldid=1639219458"